secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arch Therapeutics, Inc. (—)
CIK:        0001537561
Form:       8-K
Filed at:   2024-01-12T23:59:59+00:00
Accession:  0001437749-24-001286
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arch Therapeutics dismisses Baker Tilly, appoints Weinberg & Company as auditor
-------------------------------------------------------------------------------

- Audit committee dismissed Baker Tilly effective Jan 9, 2024; appointed Weinberg & Company.
- Baker Tilly's reports for FY2022 and FY2021 included a going concern explanatory paragraph.
- No disagreements or reportable events between the company and Baker Tilly in relevant periods.
- Baker Tilly's letter to SEC regarding this change is filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1537561/000143774924001286/0001437749-24-001286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1537561/000143774924001286/arch20240109_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-001286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer